Science 21 April 1989: Vol. 244. no. 4902, pp. 359 - 362 DOI: 10.1126/science.2523562

Prev | Table of Contents | Next

Articles

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles.

J. Jiang and G. Luo (2009)
J. Virol. 83, 12680-12691
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway.

K. Machida, J.-C. Liu, G. McNamara, A. Levine, L. Duan, and M. M. C. Lai (2009)
J. Virol. 83, 12590-12600
 |  Abstract »  |  Full Text »  |  PDF »

New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.

K Himmelsbach, D Sauter, T F Baumert, L Ludwig, H E Blum, and E Hildt (2009)
Gut 58, 1644-1653
 |  Abstract »  |  Full Text »  |  PDF »

The swinging thyroid in hepatitis C infection and interferon therapy.

H.A. Tran (2009)
QJM
 |  Full Text »  |  PDF »

Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening.

X. Yu, B. Sainz Jr., and S. L. Uprichard (2009)
Antimicrob. Agents Chemother. 53, 4311-4319
 |  Abstract »  |  Full Text »  |  PDF »

The swinging thyroid in hepatitis C infection and interferon therapy.

H. A Tran (2009)
BMJ Case Reports 2009, bcr0720080464
 |  Abstract »  |  Full Text »

Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.

Y. Cao, Y. Zhang, S. Wang, and W. Zou (2009)
Nephrol. Dial. Transplant. 24, 2745-2751
 |  Abstract »  |  Full Text »  |  PDF »

A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome.

C. Romero-Lopez and A. Berzal-Herranz (2009)
RNA 15, 1740-1752
 |  Abstract »  |  Full Text »  |  PDF »

Review: Predicting the probable outcome of treatment in HCV patients.

U. Navaneethan, N. Kemmer, and G. W. Neff (2009)
Therapeutic Advances in Gastroenterology 2, 287-302
 |  Abstract »  |  PDF »

Determinants of Hepatitis C Virus p7 Ion Channel Function and Drug Sensitivity Identified In Vitro.

C. StGelais, T. L. Foster, M. Verow, E. Atkins, C. W. G. Fishwick, D. Rowlands, M. Harris, and S. Griffin (2009)
J. Virol. 83, 7970-7981
 |  Abstract »  |  Full Text »  |  PDF »

Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA.

M. Takeshita, Y.-i. Ishida, E. Akamatsu, Y. Ohmori, M. Sudoh, H. Uto, H. Tsubouchi, and H. Kataoka (2009)
J. Biol. Chem. 284, 21165-21176
 |  Abstract »  |  Full Text »  |  PDF »

Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.

Y. Bungyoku, I. Shoji, T. Makine, T. Adachi, K. Hayashida, M. Nagano-Fujii, Y.-H. Ide, L. Deng, and H. Hotta (2009)
J. Gen. Virol. 90, 1681-1691
 |  Abstract »  |  Full Text »  |  PDF »

Treatment of hepatitis C virus core-positive hepatocytes with the transfer of recombinant caspase-3 using the 2',5'-oligoadenylate synthetase gene promoter.

Y. Wang, S. Mao, B. Li, P. Tan, D. Feng, and J. Wen (2009)
Acta Biochim Biophys Sin 41, 554-560
 |  Abstract »  |  Full Text »  |  PDF »

Systemic Autoimmune Diseases in Patients with Hepatitis C Virus Infection: Characterization of 1020 Cases (The HISPAMEC Registry).

M. RAMOS-CASALS, S. MUNOZ, F. MEDINA, L.-J. JARA, J. ROSAS, J. CALVO-ALEN, P. BRITO-ZERON, X. FORNS, J.-M. SANCHEZ-TAPIAS, and for the HISPAMEC Study Group (2009)
J Rheumatol 36, 1442-1448
 |  Abstract »  |  Full Text »  |  PDF »

Peptide inhibitors of hepatitis C virus core oligomerization and virus production.

S. Kota, C. Coito, G. Mousseau, J.-P. Lavergne, and A. D. Strosberg (2009)
J. Gen. Virol. 90, 1319-1328
 |  Abstract »  |  Full Text »  |  PDF »

Gene expression and hepatitis C virus infection.

T Asselah, I Bieche, A Sabbagh, P Bedossa, R Moreau, D Valla, M Vidaud, and P Marcellin (2009)
Gut 58, 846-858
 |  Abstract »  |  Full Text »  |  PDF »

In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor.

T.-I Lin, O. Lenz, G. Fanning, T. Verbinnen, F. Delouvroy, A. Scholliers, K. Vermeiren, A. Rosenquist, M. Edlund, B. Samuelsson, et al. (2009)
Antimicrob. Agents Chemother. 53, 1377-1385
 |  Abstract »  |  Full Text »  |  PDF »

Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3.

S. Ujino, S. Yamaguchi, K. Shimotohno, and H. Takaku (2009)
J. Biol. Chem. 284, 6841-6846
 |  Abstract »  |  Full Text »  |  PDF »

Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees.

S. S. Carroll, S. Ludmerer, L. Handt, K. Koeplinger, N. R. Zhang, D. Graham, M.-E. Davies, M. MacCoss, D. Hazuda, and D. B. Olsen (2009)
Antimicrob. Agents Chemother. 53, 926-934
 |  Abstract »  |  Full Text »  |  PDF »

Correlations of Serum Hepatitis C Virus RNA and Alanine Transaminase With Liver Histopathological Changes in Patients With Chronic Hepatitis C.

P. Liu, Y. Li, and C.-m. Sun (2009)
Lab Med 40, 167-169
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C virus entry: possible targets for therapy.

J M Timpe and J A McKeating (2008)
Gut 57, 1728-1737
 |  Full Text »  |  PDF »

Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody Detection.

S. Kim, J.-H. Kim, S. Yoon, Y.-H. Park, and H.-S. Kim (2008)
J. Clin. Microbiol. 46, 3919-3923
 |  Abstract »  |  Full Text »  |  PDF »

Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus.

J. Ji, A. Glaser, M. Wernli, J. M. Berke, D. Moradpour, and P. Erb (2008)
J. Gen. Virol. 89, 2761-2766
 |  Abstract »  |  Full Text »  |  PDF »

Kinetic Analysis by Real-Time PCR of Hepatitis C Virus (HCV)-Specific T Cells in Peripheral Blood and Liver after Challenge with HCV.

R. K. Ramalingam, D. Meyer-Olson, N. H. Shoukry, D. G. Bowen, C. M. Walker, and S. A. Kalams (2008)
J. Virol. 82, 10487-10492
 |  Abstract »  |  Full Text »  |  PDF »

The History of Tumor Virology.

R. T. Javier and J. S. Butel (2008)
Cancer Res. 68, 7693-7706
 |  Abstract »  |  Full Text »  |  PDF »

The hazards of blood transfusion in historical perspective.

H. J. Alter and H. G. Klein (2008)
Blood 112, 2617-2626
 |  Abstract »  |  Full Text »  |  PDF »

CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes.

M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, and S. Crotta (2008)
J. Virol. 82, 8316-8329
 |  Abstract »  |  Full Text »  |  PDF »

Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.

W. C.-M. Chuang and J.-P. Allain (2008)
J. Gen. Virol. 89, 1890-1900
 |  Abstract »  |  Full Text »  |  PDF »

Coordinated evolution of the hepatitis C virus.

D. S. Campo, Z. Dimitrova, R. J. Mitchell, J. Lara, and Y. Khudyakov (2008)
PNAS 105, 9685-9690
 |  Abstract »  |  Full Text »  |  PDF »

Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines.

K. Murakami, T. Kimura, M. Osaki, K. Ishii, T. Miyamura, T. Suzuki, T. Wakita, and I. Shoji (2008)
J. Gen. Virol. 89, 1587-1592
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries.

D FitzSimons, G Francois, G De Carli, D Shouval, A Pruss-Ustun, V Puro, I Williams, D Lavanchy, A De Schryver, A Kopka, et al. (2008)
Occup. Environ. Med. 65, 446-451
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Mutagenic and Chain-Terminating Nucleotide Analogs on Enzymes Isolated from Hepatitis C Virus Strains of Various Genotypes.

J. A. Heck, A. M. I. Lam, N. Narayanan, and D. N. Frick (2008)
Antimicrob. Agents Chemother. 52, 1901-1911
 |  Abstract »  |  Full Text »  |  PDF »

The role of hepatitis C virus in the pathogenesis of hepatocellular carcinoma.

G. Tran (2008)
Bioscience Horizons 1, 167-175
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk.

S. Inubushi, M. Nagano-Fujii, K. Kitayama, M. Tanaka, C. An, H. Yokozaki, H. Yamamura, H. Nuriya, M. Kohara, K. Sada, et al. (2008)
J. Gen. Virol. 89, 1231-1242
 |  Abstract »  |  Full Text »  |  PDF »

Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication.

P. Huang, D. A. Goff, Q. Huang, A. Martinez, X. Xu, S. Crowder, S. D. Issakani, E. Anderson, N. Sheng, P. Achacoso, et al. (2008)
Antimicrob. Agents Chemother. 52, 1419-1429
 |  Abstract »  |  Full Text »  |  PDF »

Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease.

C. Voisset, R. A. Weiss, and D. J. Griffiths (2008)
Microbiol. Mol. Biol. Rev. 72, 157-196
 |  Abstract »  |  Full Text »  |  PDF »

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.

N. Kaushik-Basu, A. Bopda-Waffo, T. T. Talele, A. Basu, P. R. R. Costa, A. J. M. da Silva, S. G. Sarafianos, and F. Noel (2008)
Nucleic Acids Res. 36, 1482-1496
 |  Abstract »  |  Full Text »  |  PDF »

NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System.

A. Gozdek, I. Zhukov, A. Polkowska, J. Poznanski, A. Stankiewicz-Drogon, J. M. Pawlowicz, W. Zagorski-Ostoja, P. Borowski, and A. M. Boguszewska-Chachulska (2008)
Antimicrob. Agents Chemother. 52, 393-401
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein.

T. L. Tellinghuisen, K. L. Foss, J. C. Treadaway, and C. M. Rice (2008)
J. Virol. 82, 1073-1083
 |  Abstract »  |  Full Text »  |  PDF »

A prospective study of change in visual function in patients treated with pegylated interferon alpha for hepatitis C in the UK.

N N Malik, H G Sheth, N Ackerman, N Davies, and S M Mitchell (2008)
Br J Ophthalmol 92, 256-258
 |  Abstract »  |  Full Text »  |  PDF »

The hepatitis C sequence database in Los Alamos.

C. Kuiken, P. Hraber, J. Thurmond, and K. Yusim (2008)
Nucleic Acids Res. 36, D512-D516
 |  Abstract »  |  Full Text »  |  PDF »

Differences in the expression of the hepatitis C virus core+1 open reading frame between a nuclear and a cytoplasmic expression system.

N. Vassilaki, K. I. Kalliampakou, and P. Mavromara (2008)
J. Gen. Virol. 89, 222-231
 |  Abstract »  |  Full Text »  |  PDF »

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture.

K.-S. Chang, J. Jiang, Z. Cai, and G. Luo (2007)
J. Virol. 81, 13783-13793
 |  Abstract »  |  Full Text »  |  PDF »

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model.

C.-M. Chen, Y. He, L. Lu, H. B. Lim, R. L. Tripathi, T. Middleton, L. E. Hernandez, D. W. A. Beno, M. A. Long, W. M. Kati, et al. (2007)
Antimicrob. Agents Chemother. 51, 4290-4296
 |  Abstract »  |  Full Text »  |  PDF »

Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma.

H. Feng, J. L. Taylor, P. V. Benos, R. Newton, K. Waddell, S. B. Lucas, Y. Chang, and P. S. Moore (2007)
J. Virol. 81, 11332-11340
 |  Abstract »  |  Full Text »  |  PDF »

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus.

D. X. Johansson, C. Voisset, A. W. Tarr, M. Aung, J. K. Ball, J. Dubuisson, and M. A. A. Persson (2007)
PNAS 104, 16269-16274
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort.

O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff (2007)
Psychosomatics 48, 405-411
 |  Abstract »  |  Full Text »  |  PDF »

Studying Hepatitis C Virus: Making the Best of a Bad Virus.

T. L. Tellinghuisen, M. J. Evans, T. von Hahn, S. You, and C. M. Rice (2007)
J. Virol. 81, 8853-8867
 |  Full Text »  |  PDF »

Cohort Profile: The Swiss Hepatitis C Cohort Study (SCCS).

L. Prasad, V. M. Spicher, M. Zwahlen, M. Rickenbach, B. Helbling, F. Negro, and Swiss Hepatitis C Cohort Study Group (2007)
Int. J. Epidemiol.
 |  Full Text »  |  PDF »

The NS3 Helicase and NS5B-to-3'X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells.

A. Murayama, T. Date, K. Morikawa, D. Akazawa, M. Miyamoto, M. Kaga, K. Ishii, T. Suzuki, T. Kato, M. Mizokami, et al. (2007)
J. Virol. 81, 8030-8040
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity.

Y. Li, D. F. Boehning, T. Qian, V. L. Popov, and S. A. Weinman (2007)
FASEB J 21, 2474-2485
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.

D. Saadoun, D. A. Landau, L. H. Calabrese, and P. P. Cacoub (2007)
Rheumatology 46, 1234-1242
 |  Abstract »  |  Full Text »  |  PDF »

Antibody to the Human T-Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein Gp46 in Patients Co-infected with HCV and HTLV-1.

H. Takeoka, N. Furusyo, K. Toyoda, M. Murata, Y. Sagara, S. Kashiwagi, and J. Hayashi (2007)
Am J Trop Med Hyg 77, 192-196
 |  Abstract »  |  Full Text »  |  PDF »

Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940-1990.

J. J. Goedert, B. E. Chen, L. Preiss, L. M. Aledort, P. S. Rosenberg, and for the Second Multicenter Hemophilia Cohort Study (2007)
Am. J. Epidemiol. 165, 1443-1453
 |  Abstract »  |  Full Text »  |  PDF »

Functional Interaction of Hepatitis C Virus NS5B with Nucleolin GAR Domain.

T. Kusakawa, T. Shimakami, S. Kaneko, K. Yoshioka, and S. Murakami (2007)
J. Biochem. 141, 917-927
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Diagnostics of Hepatitis C Virus Infection: A Systematic Review.

J. D. Scott and D. R. Gretch (2007)
JAMA 297, 724-732
 |  Abstract »  |  Full Text »  |  PDF »

Involvement of the PA28{gamma}-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein.

H. Miyamoto, K. Moriishi, K. Moriya, S. Murata, K. Tanaka, T. Suzuki, T. Miyamura, K. Koike, and Y. Matsuura (2007)
J. Virol. 81, 1727-1735
 |  Abstract »  |  Full Text »  |  PDF »

E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein.

M. Shirakura, K. Murakami, T. Ichimura, R. Suzuki, T. Shimoji, K. Fukuda, K. Abe, S. Sato, M. Fukasawa, Y. Yamakawa, et al. (2007)
J. Virol. 81, 1174-1185
 |  Abstract »  |  Full Text »  |  PDF »

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C.

A. Wohnsland, W. P. Hofmann, and C. Sarrazin (2007)
Clin. Microbiol. Rev. 20, 23-38
 |  Abstract »  |  Full Text »  |  PDF »

Epidemic dynamics of two coexisting hepatitis C virus subtypes.

N. Jimenez-Hernandez, M. Torres-Puente, M. A. Bracho, I. Garcia-Robles, E. Ortega, J. del Olmo, F. Carnicer, F. Gonzalez-Candelas, and A. Moya (2007)
J. Gen. Virol. 88, 123-133
 |  Abstract »  |  Full Text »  |  PDF »

Responsibilities and obligations of using human research specimens transported across national boundaries.

A S Muula and J M Mfutso-Bengo (2007)
J. Med. Ethics 33, 35-38
 |  Abstract »  |  Full Text »  |  PDF »

The Hepatitis C Virus RNA 3'-Untranslated Region Strongly Enhances Translation Directed by the Internal Ribosome Entry Site.

Y. Song, P. Friebe, E. Tzima, C. Junemann, R. Bartenschlager, and M. Niepmann (2006)
J. Virol. 80, 11579-11588
 |  Abstract »  |  Full Text »  |  PDF »

Evidence for the Formation of a Heptameric Ion Channel Complex by the Hepatitis C Virus P7 Protein in Vitro.

D. Clarke, S. Griffin, L. Beales, C. St. Gelais, S. Burgess, M. Harris, and D. Rowlands (2006)
J. Biol. Chem. 281, 37057-37068
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor {alpha} expression via activation of nuclear factor-{kappa}B.

Y Sato, J Kato, R Takimoto, K Takada, Y Kawano, K Miyanishi, M Kobune, Y Sato, T Takayama, T Matunaga, et al. (2006)
Gut 55, 1801-1808
 |  Abstract »  |  Full Text »  |  PDF »

Multiplex Real-Time Reverse Transcription-PCR Assay for Determination of Hepatitis C Virus Genotypes.

L. Cook, K. Sullivan, E. M. Krantz, A. Bagabag, and K. R. Jerome (2006)
J. Clin. Microbiol. 44, 4149-4156
 |  Abstract »  |  Full Text »  |  PDF »

Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia..

D. Saadoun, J. Sellam, P. Ghillani-Dalbin, R. Crecel, J.-C. Piette, and P. Cacoub (2006)
Arch Intern Med 166, 2101-2108
 |  Abstract »  |  Full Text »  |  PDF »

Novel robust hepatitis C virus mouse efficacy model..

Q. Zhu, Y. Oei, D. B. Mendel, E. N. Garrett, M. B. Patawaran, P. W. Hollenbach, S. L. Aukerman, and A. J. Weiner (2006)
Antimicrob. Agents Chemother. 50, 3260-3268
 |  Abstract »  |  Full Text »  |  PDF »

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon..

S. Ma, J. E. Boerner, C. TiongYip, B. Weidmann, N. S. Ryder, M. P. Cooreman, and K. Lin (2006)
Antimicrob. Agents Chemother. 50, 2976-2982
 |  Abstract »  |  Full Text »  |  PDF »

High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity..

L. A. Jones, L. E. Clancy, W. D. Rawlinson, and P. A. White (2006)
Antimicrob. Agents Chemother. 50, 3019-3027
 |  Abstract »  |  Full Text »  |  PDF »

Treating viral hepatitis C: efficacy, side effects, and complications..

M P Manns, H Wedemeyer, and M Cornberg (2006)
Gut 55, 1350-1359
 |  Full Text »  |  PDF »

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses..

M. Vajdy, M. Selby, A. Medina-Selby, D. Coit, J. Hall, L. Tandeske, D. Chien, C. Hu, D. Rosa, M. Singh, et al. (2006)
J. Gen. Virol. 87, 2253-2262
 |  Abstract »  |  Full Text »  |  PDF »

Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities..

K.-S. Chang, Z. Cai, C. Zhang, G. C. Sen, B. R. G. Williams, and G. Luo (2006)
J. Virol. 80, 7364-7374
 |  Abstract »  |  Full Text »  |  PDF »

Relationships between Hepatitis C Virus Replication and CXCL-8 Production In Vitro..

B. C. A. Koo, P. McPoland, J. P. Wagoner, O. J. Kane, V. Lohmann, and S. J. Polyak (2006)
J. Virol. 80, 7885-7893
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Interleukin-6 by Hepatitis C Virus Core Protein in Hepatitis C-Associated Mixed Cryoglobulinemia and B-Cell Non-Hodgkin's Lymphoma.

G. Feldmann, H. D. Nischalke, J. Nattermann, B. Banas, T. Berg, C. Teschendorf, W. Schmiegel, U. Duhrsen, J. Halangk, A. Iwan, et al. (2006)
Clin. Cancer Res. 12, 4491-4498
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis.

E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski, and Y. Rouille (2006)
J. Virol. 80, 6964-6972
 |  Abstract »  |  Full Text »  |  PDF »

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKK{varepsilon} Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage..

R. Lin, J. Lacoste, P. Nakhaei, Q. Sun, L. Yang, S. Paz, P. Wilkinson, I. Julkunen, D. Vitour, E. Meurs, et al. (2006)
J. Virol. 80, 6072-6083
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Cellular Factors Associated with the 3'-Nontranslated Region of the Hepatitis C Virus Genome.

D. Harris, Z. Zhang, B. Chaubey, and V. N. Pandey (2006)
Mol. Cell. Proteomics 5, 1006-1018
 |  Abstract »  |  Full Text »  |  PDF »

The NS5A Protein of the Hepatitis C Virus Genotype 1a Is Cleaved by Caspases to Produce C-terminal-truncated Forms of the Protein That Reside Mainly in the Cytosol.

M. Kalamvoki, U. Georgopoulou, and P. Mavromara (2006)
J. Biol. Chem. 281, 13449-13462
 |  Abstract »  |  Full Text »  |  PDF »

Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein..

S. Sato, M. Fukasawa, Y. Yamakawa, T. Natsume, T. Suzuki, I. Shoji, H. Aizaki, T. Miyamura, and M. Nishijima (2006)
J. Biochem. 139, 921-930
 |  Abstract »  |  Full Text »  |  PDF »

Antiviral effect of {alpha}-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles..

C. Chapel, C. Garcia, P. Roingeard, N. Zitzmann, J. Dubuisson, R. A. Dwek, C. Trepo, F. Zoulim, and D. Durantel (2006)
J. Gen. Virol. 87, 861-871
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Hepatitis C Virus (HCV) NS5B-Nucleolin Interaction on HCV Replication with HCV Subgenomic Replicon..

T. Shimakami, M. Honda, T. Kusakawa, T. Murata, K. Shimotohno, S. Kaneko, and S. Murakami (2006)
J. Virol. 80, 3332-3340
 |  Abstract »  |  Full Text »  |  PDF »

From the Cover: Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

B. D. Lindenbach, P. Meuleman, A. Ploss, T. Vanwolleghem, A. J. Syder, J. A. McKeating, R. E. Lanford, S. M. Feinstone, M. E. Major, G. Leroux-Roels, et al. (2006)
PNAS 103, 3805-3809
 |  Abstract »  |  Full Text »  |  PDF »

Analysis of Mutations within the 5' Untranslated Region, Interferon Sensitivity Region, and PePHD Region as a Function of Response to Interferon Therapy in Hepatitis C Virus-Infected Patients in India..

R. Gupta, M. Subramani, M. N. Khaja, C. Madhavi, S. Roy, C. M. Habibullah, and S. Das (2006)
J. Clin. Microbiol. 44, 709-715
 |  Abstract »  |  Full Text »  |  PDF »

SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells.

B. A. Malcolm, R. Liu, F. Lahser, S. Agrawal, B. Belanger, N. Butkiewicz, R. Chase, F. Gheyas, A. Hart, D. Hesk, et al. (2006)
Antimicrob. Agents Chemother. 50, 1013-1020
 |  Abstract »  |  Full Text »  |  PDF »

Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo.

S. Pal, M. C. Shuhart, L. Thomassen, S. S. Emerson, T. Su, N. Feuerborn, J. Kae, and D. R. Gretch (2006)
J. Virol. 80, 2280-2290
 |  Abstract »  |  Full Text »  |  PDF »

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients.

S. U. Nielsen, M. F. Bassendine, A. D. Burt, C. Martin, W. Pumeechockchai, and G. L. Toms (2006)
J. Virol. 80, 2418-2428
 |  Abstract »  |  Full Text »  |  PDF »

Application of sequence-based methods in human microbial ecology.

L. Weng, E. M. Rubin, and J. Bristow (2006)
Genome Res. 16, 316-322
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C: a review for primary care physicians.

T. Wong and S. S. Lee (2006)
Can. Med. Assoc. J. 174, 649-659
 |  Abstract »  |  Full Text »  |  PDF »

Management of Hepatitis C Infection in the HIV-Infected Patient.

K. McNelis (2006)
Journal of Pharmacy Practice 19, 37-52
 |  Abstract »  |  PDF »

Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6.

K. Machida, K. T. H. Cheng, V. M.-H. Sung, A. M. Levine, S. Foung, and M. M. C. Lai (2006)
J. Virol. 80, 866-874
 |  Abstract »  |  Full Text »  |  PDF »

Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees.

O. V. Nainan, L. Lu, F.-X. Gao, E. Meeks, B. H. Robertson, and H. S. Margolis (2006)
J. Gen. Virol. 87, 83-91
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products